Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

The oblivion of ignoring the obvious

This article was originally published in Scrip

Executive Summary

Several very large pharmaceutical companies each of which boasts a long history of competence in dealing with government regulatory bodies have somehow failed to take the hint with regard to the requirements of the German reimbursement system.



Related Companies